Author: Andrew Horowitz

Good News for Hedge Fund Rats

Geron (GERN) a biotech company involved in Stem Cell research announced that they have seen success as human stem cells proved regenerative in the damaged hearts of rats.

The Menlo Park, Calif., biopharmaceutical company said the study’s data demonstrated that heart muscle cells derived from human embryonic stem cells improved heart...

Read More

Press: Interview on thestreet.com

I spent some time today talking with my friend Aaron Task from thestreet.com. Aaron is a very bright guy and has a keen understanding of the markets. Lately, he has been thinking about the volatile market action and is looking to find evidence that will show if we are in...

Read More

Bank of America – Last Man Standing

There is a fine line between brilliance and stupidity. In the world of finance and investing, that line can sometimes be measured by risk and reward. If the decision made by an investor turns out to be profitable, then we look at the outcome as a result of either luck...

Read More

TDI Podcast 24: Trust and Transparency

Guests: John Dvorak, John Havens and Parker Conrad. Who can you trust when looking for investment and financial advice? We discuss Trust and Transparency in the modern age.

There is so much information out there and we take a deep look at the problems with mixing amateurs and pros in the...

Read More

Glancing Blow or Eye of the Storm?

If the markets were to be compared to a hurricane, we could say that the front wall has passed and we are now in the eye. This is one of natureā€˜s wonders that is both beautiful and potentially deadly.

During the period that the eye passes over, skies are blue, the...

Read More